Weed (BUDZ) Shares Outstanding (Weighted Average) (2010 - 2026)

Weed (BUDZ) recorded quarterly Shares Outstanding (Weighted Average) of $148.3 million in Q1 2026, up 0.6% quarter-over-quarter from $147.4 million in Q4 2025, and up 9.11% on a YoY basis from $135.9 million in Q1 2025.

Weed (BUDZ) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Weed's Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $148.3 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 9.11% year-over-year to $148.3 million; the TTM figure through Mar 2026 stood at $148.3 million (up 9.11% YoY), while the FY2025 annual figure was $147.4 million, up 18.77% from the prior year.
  • Shares Outstanding (Weighted Average) was $148.3 million for Q1 2026 at Weed, up from $147.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $148.3 million in Q1 2026 to a low of $119.9 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $128.4 million across 5 years, with a median of $123.8 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) climbed 0.26% in 2024, then gained 18.77% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $122.1 million in 2022, then increased by 1.34% to $123.7 million in 2023, then advanced by 0.34% to $124.1 million in 2024, then climbed by 18.77% to $147.4 million in 2025, then advanced by 0.6% to $148.3 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $148.3 million (Q1 2026), $147.4 million (Q4 2025), and $135.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 Weed - - - 148.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 148.31 Mn
Dec 31, 2025 147.43 Mn
Sep 30, 2025 135.93 Mn
Jun 30, 2025 135.93 Mn
Mar 31, 2025 135.93 Mn
Dec 31, 2024 124.13 Mn
Sep 30, 2024 125.68 Mn
Jun 30, 2024 125.18 Mn
Mar 31, 2024 123.81 Mn
Dec 31, 2023 123.71 Mn
Sep 30, 2023 123.48 Mn
Jun 30, 2023 123.48 Mn
Mar 31, 2023 123.48 Mn
Dec 31, 2022 122.08 Mn
Sep 30, 2022 122.94 Mn
Jun 30, 2022 121.91 Mn
Mar 31, 2022 119.93 Mn
Dec 31, 2021 116.73 Mn
Sep 30, 2021 117.92 Mn
Jun 30, 2021 115.15 Mn